Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer

Our findings highlight the potential of p62 as a new prognostic marker for ovarian cancer patients and p62's associated autophagy pathway may be a promising therapeutic target to prevent metastasis, recurrence and to reverse drug resistance in ovarian cancer.